Specific ligand binding on genetic variants of human α 1-acid glycoprotein studied by circular dichroism spectroscopy

Biochemical Pharmacology

Volumn 67, Issue 4, 2004, Pages 679-688

  Fitos, Ilona ^a   Visy, Júlia ^a   Zsila, Ferenc ^a   Bikádi, Zsolt ^a   Mády, György ^a   Simonyi, Miklós ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Acridine orange; Dicumarol; Genetic variants; Imipramine; Induced circular dichroism; 1 Acid glycoprotein

Indexed keywords

ACRIDINE ORANGE; DICOUMAROL; OROSOMUCOID;

ARTICLE; BINDING AFFINITY; CHIRALITY; CIRCULAR DICHROISM; DNA DRUG COMPLEX; DRUG BINDING; DRUG CONFORMATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; LIGAND BINDING; MOLECULAR INTERACTION; PRIORITY JOURNAL;

EID: 1642442421     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.09.039     Document Type: Article

References (36)

1. Fournier T., Medjoubi-N N., Porquet D. Alpha-1-acid glycoprotein. Biochim. Biophys. Acta. 1482:2000;157-171.
2. Lögdberg L., Wester L. Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses. Biochim. Biophys. Acta. 1482:2000;284-297.
3. 1-Acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev. 14:2003;25-34.
4. Kremer J.M.H., Wilting J., Janssen L.H.M. Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol. Rev. 40:1988;1-47.
5. Israili Z.H., Dayton P.G. Human alpha-1-acid glycoprotein and its interactions with drugs. Drug Metab. Rev. 33:2001;161-235.
6. Eap C.B., Baumann P. Isoelectric focusing of alpha-1-acid glycoprotein (orosomucoid) in immobilized pH gradients with 8 M urea: detection of its desialylated variants using an alkaline phosphatase-linked secondary antibody system. Electrophoresis. 9:1988;650-654.
7. Eap C.B., Cuendet C., Baumann P. Orosomucoid (alpha-1-acid glycoprotein) phenotyping by use of immobilized pH gradients with 8 M urea and immunoblotting. A new variant encountered in a population study. Hum. Genet. 80:1988;183-185.
8. Dente L., Pizza M.G., Metspalu A., Cortese R. Structure and expression of the genes coding for human alpha-1-acid glycoprotein. EMBO J. 6:1987;2289-2296.
9. Tomei L., Eap C.B., Baumann P., Dente L. Use of transgenic mice for the characterization of human alpha-1-acid glycoprotein (orosomucoid) variants. Hum. Genet. 84:1989;89-91.
10. Yuasa I., Weidinger S., Umetsu K., Suenaga K., Ishimoto G., Eap C.B., Duché J.C., Baumann P. Orosomucoid system: 17 additional orosomucoid variants and proposal for a new nomenclature. Vox Sang. 64:1993;47-55.
11. Eap C.D., Cuendet C., Baumann P. Selectivity in the binding of psychotropic drugs to the variants of human alpha-1-acid glycoprotein. Naunyn Schmiedebergs Arch. Pharmacol. 337:1988;220-224.
12. 1-acid glycoprotein and its variants. J. Pharm. Pharmacol. 40:1988;767-770.
13. 1-acid glycoprotein in the native form by chromatography on an immobilized copper(II) affinity adsorbent. Heterogeneity of the separate variants by isoelectrofocusing and by concanavalin A affinity chromatography. J. Chromatogr. 615:1993;47-57.
14. Hervé F., Gomas E., Duché J.-C., Tillement J.-P. Evidence for differences in the binding of drugs to the two main genetic variants of human alpha-1-acid glycoprotein. Br. J. Clin. Pharmacol. 36:1993;241-249.
15. 1-acid glycoprotein. Pharmacogenetics. 6:1996;403-415.
16. 1-acid glycoprotein: generation of a three-dimensional quantitative structure-activity relationship model for drug binding to the A variant. Mol. Pharmacol. 54:1998;129-138.
17. Bertucci C., Domenici E. Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. Curr. Med. Chem. 9:2002;1463-1481.
18. 1-acid glycoprotein. Chem. Pharm. Bull. 38:1990;1688-1691.
19. 1-acid glycoprotein using circular dichroism spectroscopy. Chem. Pharm. Bull. 36:1988;4958-4962.
20. 1-acid glycoprotein. Biochem. Pharmacol. 42:1991;729-733.
21. 1-acid glycoprotein systems by protriptyline. Biochem. Pharmacol. 43:1992;2161-2167.
22. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Zakrzewski VG, Montgomery JA, Stratmann RE, Burant JC, Dapprich S, Millam JM, Daniels AD, Kudin KN, Strain MC, Farkas O, Tomasi J, Barone V, Cossi M, Cammi R, Mennucci B, Pomelli C, Adamo C, Clifford S, Ochterski J, Petersson GA, Ayala PY, Cui Q, Morokuma K, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Cioslowski J, Ortiz JV, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromo I, Gomperts R, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Gonzalez C, Challacombe M, Gill PMW, Johnson BG, Chen W, Wong MW, Andres JL, Head-Gordon M, Replogle ES, Pople JA. Gaussian 98, revision A.11. Pittsburgh PA: Gaussian, Inc.; 2001.
23. Downing JW. Program package DZDO 4.02. Boulder, USA: Department of Chemistry and Biochemistry, University of Colorado.
24. 1-acid glycoprotein in enantioselective binding of basic drugs as studied by high performance frontal analysis/capillary electrophoresis. Pharm. Res. 18:2001;389-393.
25. Lyles M.B., Cameron I.L. Interactions of the DNA intercalator acridine orange, with itself, with caffeine, and with double stranded DNA. Biophys. Chem. 96:2002;53-76.
26. Hutchinson D.W., Tomlinson J.A. The structure of dicumarol and related compounds. Tetrahedron. 25:1969;2531-2537.
27. Lightner D.A., Wijekoon W.M.D., Zhang M.-H. Understanding bilirubin conformation and binding. Circular dichroism of human serum albumin complexes with bilirubin and its esters. J. Biol. Chem. 263:1988;16669-16676.
28. Murakami K., Mizuguchi K., Kubota Y., Fujisaki Y. Equilibrium and kinetic studies of the dimerization of acridine orange and its 10-alkyl derivatives. Bull. Chem. Soc. Jpn. 59:1986;3393-3397.
29. Stryer L., Blout E.R. Optical rotatory dispersion of dyes bound to macromolecules. Cationic dyes: polyglutamic acid complexes. J. Am. Chem. Soc. 83:1961;1411-1418.
30. Neville D.M., Bradley D.F. Anomalous rotatory dispersion of acridine orange-native deoxyribonucleic acid (DNA) complexes. Biochim. Biophys. Acta. 50:1961;397-399.
31. Gardner B.J., Mason S.F. Structure and optical activity of the DNA-aminoacridine complex. Biopolymers. 5:1967;79-94.
32. Fornasiero D., Kurucsev T. Circular-dichroism spectra and the interaction between acridine-dyes and deoxyribonucleic-acid. J. Phys. Chem. 85:1981;613-618.
33. 1-acid glycoprotein and its high-affinity binding site. Biochem. Biophys. Res. Commun. 300:2003;41-46.
34. 1-acid glycoprotein. J. Pharm. Sci. 90:2001;1407-1423.
35. 1-acid glycoprotein. J. Pharmacol. Exp. Ther. 304:2003;71-80.
36. Li J.-H., Xu J.-Q., Cao X.-M., Ni L., Li Y., Zhuang Y.-Y., Gong J.-B. Influence of the ORM1 phenotypes on serum unbound concentration and protein binding of quinidine. Clin. Chim. Acta. 317:2002;85-92.